First test of 'Reinforced' immune cells for Kids' tough cancers
NCT ID NCT01875601
Summary
This early-stage study tested a new immune therapy for children and young adults whose solid tumors did not respond to standard treatments. Doctors collected and grew a patient's own 'natural killer' (NK) immune cells, then gave them back to the patient to fight the cancer. The main goals were to see if this process was safe and possible, and to test if adding a drug called rhIL15 could make the cells work better.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.